SecBot SecBot

Reducing Hereditary Cancer Act of 2025

S. 2760 Sen. Lisa Murkowski (R-AK) In committee
  1. Introduced Sep 10
  2. Committee Sep 10
  3. Passed Senate Next
  4. Passed House Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Sep 10, 2025Next: Senate vote
413d ago Sep 10, 2025: Read twice and referred to the Committee on Finance.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
1company, 3 filings
Member trades
1trades in the last 90 days
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

1 company
Companies by sector
Financials 1
Search all 1 companies, their asks and price moves Subscribe

Summary

Reducing Hereditary Cancer Act of 2025

Full summary1 paragraphs

This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.

Library of Congress summary, Sep 10, 2025

Summary versions
  • Introduced in SenateSep 10, 2025

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.